ISN-KDIGO CKD EARLY IDENTIFICATion & Intervention Toolkit
Chronic kidney disease (CKD) causes substantial global morbidity and increases cardiovascular and all-cause mortality, so identifying and treating it at the earliest stages is a worldwide imperative.
To this end, the ISN and KDIGO released a series of tools for CKD early identification and intervention aimed at kidney health professionals, primary care physicians and nurses working in primary care settings.
Discover and access these tools below.
This quick guide aims to further clarify the ISN-KDIGO CKD Early Identification and Intervention booklet to allow easy, widespread adoption and prompt action around early identification and intervention of CKD in the primary care setting.
Download the guide
- From our colleagues in Malaysia, we have heard that for “Step 2”, the uACR measurement is needed to progress to “Step 3”. If uACR is not easily available or affordable in your setting, you can use a uACR converter, which can give you the equivalent uACR for a U dipstick or uPCR reading.
If anyone finds an inadvertent language or content error, kindly be in touch with us at rblondel@theisn.org. These documents were last updated as of December 2022.
Implementing Early CKD Detection Programs Series: Case Studies from Around the World
WCN’24 Spotlight Session: Latin America
ISN Webinar: Asia and Newly Independent States
ISN Webinar: Europe, Africa and the Middle East
X Spaces
Webinars
ISN-KDIGO Webinar: Chronic Kidney Disease Early Identification & Intervention
The Compelling Case for Early Detection and Treatment of CKD
Leadership and CKD Screening
Visit this page to find resources for people living with kidney disease. Resources available include:
- Patient stories
- A map of local patient organisations
- Information on kidney health
Steering Committee
- Adeera Levin | Canada
- Vivekanand Jha | India
- Elliot Koranteng Tannor | Ghana
- Laura Sola | Uruguay
- Roberto Pecoits-Filho | USA
- Sunita Bavanandan | Malaysia
This activity is supported by an independent medical educational grants from AstraZeneca and Boehringer Ingelheim.
This toolkit material is freely available for download by health care professionals and individual usage. For-profit organizations may link to toolkit materials with appropriate referencing but are not allowed to use the materials directly (including screenshots) in their own activities; and, where the toolkit materials are referenced with a link, society logos may not be used or displayed with the link. Non-profit organizations may link to the toolkit materials with appropriate referencing, and may promote the materials directly, but must seek permission for this first. If you have any questions concerning the rights to use these materials, please contact mmoorthy@theisn.org.
For any inquiries on this initiative, please contact Monica Moorthy at mmoorthy@theisn.org.
For any inquiries/feedback on the resources provided in this toolkit, contact KDIGO at kdigocommunications@kdigo.org.
Partner
This initiative is led in collaboration with Kidney Disease Improving Global Outcomes (KDIGO).
Disclaimer text: This toolkit is intended to facilitate decision making of health professionals in their daily practice. However, final decisions concerning an individual patient must be made by the responsible health professional(s) in consultation with the patient and caregiver as appropriate. All societies represented in this project decline any responsibilities for any damage caused by the use that may be made of the information provided in this toolkit.